Higher Temperatures Tied to Greater Risk for Mortality in People Undergoing Dialysis
By Lori Solomon HealthDay Reporter
WEDNESDAY, April 23, 2025 -- Moderately elevated ambient temperature is associated with increased mortality in patients undergoing dialysis, according to a study published in the February issue of the Clinical Kidney Journal.
Cécile Couchoud, M.D., Ph.D., from Agence de la biomédecine in Saint Denis La Plaine, France, and colleagues conducted a retrospective cohort study to investigate the association between high temperatures and mortality for patients with chronic kidney disease stage 5 treated with dialysis or with a kidney graft (2012 to 2022). The analysis included 116,808 patients undergoing dialysis and 64,531 patients with a kidney graft.
The researchers found that between June and September during 2012 to 2022, temperatures varied from 6.7 to 45.4 degrees Celsius. During this period, there were 20,174 deaths among patients undergoing dialysis and 3,340 among patients with a kidney graft. Among those undergoing dialysis, a maximum temperature >32.5 degrees Celsius was associated with higher mortality (incidence ratio, 1.09). There was no such association observed among patients with a kidney graft.
"Further analyses are needed to confirm these results and better understand the biological and clinical impact of heat intensity and the cumulative effect with other environmental factors such as air pollution," the authors write. "More detailed studies on reasons for hospitalizations and causes of death are also planned."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-24 06:00
Read more

- Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
- 23 States Sue Over $12B in Public Health Cuts
- Risk for Long COVID Lower in Pregnant Individuals
- Half-Million Children Could Die If U.S. AIDS Relief Is Dropped
- Cancer Mortality Continuing to Decline
- FDA Delays Final Approval of Novavax COVID Vaccine
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions